Varenicline Tablet, Film Coated
Product Images NDC 72162-2219

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 72162-2219). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A bar graph titled 'Continuous Abstinence, Weeks 9 through 12' comparing the percentage of continuous abstinence among different treatment groups across five studies. The treatments shown include various doses of Varenicline (0.5 mg, 1.0 mg), Bupropion SR 150 mg, and Placebo. Each study group has corresponding bars with error bars indicating variability in the data.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A bar chart titled 'Continuous Abstinence, Weeks 9 through 52' comparing the percentage of continuous abstinence across different treatment groups and studies. The chart shows four groups across five studies: Varenicline 0.5 mg BID, Varenicline 1.0 mg BID, Varenicline Flexible, Bupropion SR 150 mg BID, and Placebo. Error bars indicate variability in the data.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A line graph comparing the percentage of continuous abstinent subjects over nontreatment follow-up weeks for Varenicline 1.0 mg twice daily versus placebo. The x-axis represents weeks of follow-up, while the y-axis shows the percentage of continuous abstinence, with Varenicline consistently maintaining higher abstinence rates than placebo throughout the period.*
FDA Label Image

Label (Lbl721622219)

Label (Lbl721622219)
Label for Varenicline Tablets 1 mg, film-coated oral tablets. The label includes a quantity of 56 tablets, with NDC 72162-2219-2, labeled by Bryant Ranch Prepack and manufactured by Apotex Inc. Storage instructions and pharmacist dispensing instructions are also shown, including temperature conditions and child-resistant container requirements.*
FDA Label Image

Structure-1 (Structure 1)

Structure-1 (Structure 1)
Chemical structure diagram depicting the molecular structure of varenicline, the active ingredient in the VARENICLINE tablets, showing detailed atomic bonds and groups relevant to its chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.